A new cancer cell detection method using an infectivity-enhanced adenoviral vector

Area of Science:

• Biotechnology
• Molecular Biology
• Oncology

Background:

• Cytological examination is a common diagnostic method, but its accuracy is limited by sampling errors and sample quality.
• Low numbers of malignant cells or low-grade atypia can reduce the diagnostic yield of conventional cytology.
• There is a need for more sensitive and reliable methods for early cancer detection.

Purpose of the Study:

• To develop a new cancer cell detection tool utilizing the high infectivity of adenovirus.
• To enhance adenoviral infectivity for improved sensitivity in cancer diagnosis.
• To validate the efficacy of this novel tool in detecting epithelial-derived cancer cells in various body fluid samples.

Main Methods:

• Adenoviral vectors were engineered to express luciferase for signal detection.
• Adenoviral fiber proteins were modified to enhance infectivity towards epithelial cells.
• The diagnostic tool's sensitivity was tested using the NCI-H1299 lung cancer cell line and validated in clinical body fluid samples.

Main Results:

• The engineered adenovirus demonstrated efficient transfection of lung cancer cells (NCI-H1299) with high sensitivity.
• Detection of luciferase signals was achieved with as few as 10 cancer cells.
• The adenovirus tool successfully confirmed diagnoses in body fluid samples from patients with epithelial-derived malignant and benign cancers.

Conclusions:

• This study presents a proof-of-concept for a novel, highly sensitive diagnostic tool for epithelial-derived cancers.
• Enhanced adenoviral vectors offer a promising approach to overcome limitations of traditional cytological examination.
• The developed method has the potential to significantly improve the reliability and sensitivity of cancer diagnostics.